NCT03980847View on ClinicalTrials.gov

Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

March 10, 2019

Study Completion Date

April 25, 2019

Conditions
Bone Resorption
Interventions
DRUG

Alendronate 20 mg

The Alendronate 20 mg combined with nanocrystalline hydroxyapatite as a synthetic bone substitute for socket preservation after tooth extraction

PROCEDURE

Nanocrystal hydroxyapatite

Postextraction Sockets Preserved With Nanocrystal hydroxyapatite as a synthetic bone substitute alone as a bone graft

Trial Locations (1)

19

Amirhossein Farahmand, Tehran

All Listed Sponsors
lead

Islamic Azad University, Sanandaj

OTHER

NCT03980847 - Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket | Biotech Hunter | Biotech Hunter